Literature DB >> 12552109

A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA.

Gustavo Tiscornia1, Oded Singer, Masahito Ikawa, Inder M Verma.   

Abstract

We describe the use of lentiviral vectors expressing small interfering RNAs (siRNAs) to knock down the expression of specific genes in vitro and in vivo. A lentiviral vector capable of generating siRNA specific for GFP after transduction of 293T-GFP cell lines showed no GFP fluorescence. Furthermore, no GFP-specific RNA could be detected. When eggs from GFP-positive transgenic mice were transduced with lentivirus-expressing siGFP virus, reduced fluorescence could be seen in blastocysts. More interestingly, pups from F(1) progeny, which expressed siGFP, showed considerably diminished fluorescence and decreased GFP. We propose that an approach of combining transgenesis by lentiviral vectors expressing siRNAs can be used successfully to generate a large number of mice in which the expression of a specific gene(s) can be down-regulated substantially. We believe that this approach of generating "knockdown" mice will aid in functional genomics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12552109      PMCID: PMC149921          DOI: 10.1073/pnas.0437912100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.

Authors:  Patrick J Paddison; Amy A Caudy; Emily Bernstein; Gregory J Hannon; Douglas S Conklin
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

3.  A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.

Authors:  Guangchao Sui; Christina Soohoo; El Bachir Affar; Frédérique Gay; Yujiang Shi; William C Forrester; Yang Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

4.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors.

Authors:  Carlos Lois; Elizabeth J Hong; Shirley Pease; Eric J Brown; David Baltimore
Journal:  Science       Date:  2002-01-10       Impact factor: 47.728

7.  Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos.

Authors:  Alexander Pfeifer; Masahito Ikawa; Yelena Dayn; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

8.  Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.

Authors:  A Pfeifer; T Kessler; S Silletti; D A Cheresh; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

9.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

10.  A third-generation lentivirus vector with a conditional packaging system.

Authors:  T Dull; R Zufferey; M Kelly; R J Mandel; M Nguyen; D Trono; L Naldini
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

View more
  169 in total

1.  MDDD, a 4,9-diazapyrenium derivative, is selectively toxic to glioma cells by inducing growth arrest at G0/G1 independently of p53.

Authors:  De-Hua Yu; James Macdonald; Steve Josephs; Qi Liu; Vivian Nguy; Yitzhak Tor; Flossie Wong-Staal; Qi-Xiang Li
Journal:  Invest New Drugs       Date:  2006-11       Impact factor: 3.850

2.  The specifics of small interfering RNA specificity.

Authors:  Andrew Dillin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

3.  Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.

Authors:  Maciej Wiznerowicz; Didier Trono
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  An enhanced U6 promoter for synthesis of short hairpin RNA.

Authors:  Xu Gang Xia; Hongxia Zhou; Hongliu Ding; El Bashir Affar; Yang Shi; Zuoshang Xu
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

5.  CRE recombinase-inducible RNA interference mediated by lentiviral vectors.

Authors:  Gustavo Tiscornia; Vinay Tergaonkar; Francesco Galimi; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-30       Impact factor: 11.205

6.  A universal transgene silencing method based on RNA interference.

Authors:  Philippe-Emmanuel Mangeot; François-Loïc Cosset; Pierre Colas; Ivan Mikaelian
Journal:  Nucleic Acids Res       Date:  2004-07-12       Impact factor: 16.971

Review 7.  Silence of the genes.

Authors:  Oded Singer; Amiel Yanai; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

Review 8.  Pharmaceutical prospects for RNA interference.

Authors:  Raymond M Schiffelers; Martin C Woodle; Puthupparampil Scaria
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

9.  Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis.

Authors:  Shihua Lu; Bryan R Cullen
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 10.  Applications of lentiviral vectors for shRNA delivery and transgenesis.

Authors:  Oded Singer; Inder M Verma
Journal:  Curr Gene Ther       Date:  2008-12       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.